{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:38:13Z","timestamp":1790271493732,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007210","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The World Health Organization (WHO) recognises dementia as a public health priority. Currently, more than 55\u00a0million people live with dementia, and this figure is expected to almost triple to 139\u00a0million by 2050. Alzheimer\u2019s disease is the most common cause of dementia, and there is still no cure. Despite the availability of symptomatic and first disease-modifying treatments, effective treatment remains limited. This makes it even more important to be aware that it is estimated that nearly half of all dementia cases could be prevented by eliminating 14 major risk factors. Consequently, the role of these modifiable risk factors has been the subject of research to inform effective preventive strategies. This narrative review summarises the current evidence on the prevention of cognitive decline and dementia. First, we provide an overview of the\n                    <jats:italic>current state<\/jats:italic>\n                    on risk factors, multimodal clinical controlled trials for slowing down or preventing dementia and primordial, primary, secondary, tertiary and quaternary prevention of cognitive decline and dementia. Second, we evaluate knowledge and action\n                    <jats:italic>gaps<\/jats:italic>\n                    in the field. Finally, we discuss how to address these gaps and what the\n                    <jats:italic>next steps<\/jats:italic>\n                    should be. Overall, to accelerate progress, the following key calls to action are paramount: (1) making prevention of cognitive decline and dementia a priority; (2) promoting brain health throughout the lifespan through coordinated intersectoral action targeting key risk factors; (3) improving access to diagnosis and treatment for patients with cognitive decline and dementia; and (4) encouraging research on prevention and how to translate knowledge into action.\n                  <\/jats:p>","DOI":"10.1186\/s42466-026-00494-4","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:05:29Z","timestamp":1776776729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The best treatment is prevention: prevention of cognitive decline and dementia \u2013 current state, gaps and next steps \u2013"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9730-9228","authenticated-orcid":false,"given":"Kathrin","family":"Reetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Liepelt-Scarfone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"H\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Fl\u00f6el","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg B.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Dementia Commission of the German Society for Neurology (DGN)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"von Arnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dodel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Duning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Kaluza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcnte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Kleineberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothee","family":"Saur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Nellessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja Christine","family":"Schwichtenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"494_CR1","doi-asserted-by":"crossref","unstructured":"[WHO], W. H. O. (2021). Global Status Report On The Public Health Response to Dementia.","DOI":"10.1016\/S2468-2667(21)00215-2"},{"key":"494_CR2","doi-asserted-by":"publisher","unstructured":"Arthurton, L., Barbarino, P., Anderson, R., Schlaepfer, B., Salehi, N., & Knapp, M. (2025). Dementia is a neglected noncommunicable disease and leading cause of death. Nature Reviews Neurology(2). https:\/\/doi.org\/10.1038\/s41582-024-01051-w","DOI":"10.1038\/s41582-024-01051-w"},{"key":"494_CR3","unstructured":"[WHO], W. H. O. Optimizing brain health across the life course: WHO position paper.https:\/\/iris.who.int\/bitstream\/handle\/10665\/361251\/ 9789240054 561- eng.pdf?sequence\u2009=\u20091. https:\/\/iris.who.int\/bitstream\/handle\/10665\/361251\/ 9789240054 561- eng.pdf?sequence\u2009=\u20091."},{"key":"494_CR4","unstructured":"DGN. S3-Leitlinie Demenzen. DGN eV & DGPPN eV (Hrsg.) (2023). ;: https:\/\/register.awmf.org\/de\/leitlinien\/detail\/038-013"},{"key":"494_CR5","first-page":"470","volume":"120","author":"I Blotenberg","year":"2023","unstructured":"Blotenberg, I., Hoffmann, W., & Thyrian, J. R. (2023). Dementia in Germany: Epidemiology and prevention potential. Deutsches Arzteblatt International, 120, 470\u2013476.","journal-title":"Deutsches Arzteblatt International"},{"key":"494_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston, G., Huntley, J., Liu, K. Y., et al. (2024). Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet, 404, 572\u2013628.","journal-title":"Lancet"},{"key":"494_CR7","unstructured":"WHO GWHO. Global action plan on the public health response to dementia 2017\u20132025. Geneva: World HealthOrganization (2017). Licence: CC BY-NC-SA 3.0 IGO. World Health Organization 2017. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"494_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16589","volume":"32","author":"PAJM Boon","year":"2025","unstructured":"Boon, P. A. J. M., Berger, T., Leonardi, M., et al. (2025). A roadmap toward promoting and improving brain health in Europe and closing the awareness and funding gap. European Journal of Neurology, 32, Article e16589.","journal-title":"European Journal of Neurology"},{"key":"494_CR9","unstructured":"Falkei, Fl\u00f6el, A., Glanz, K. (2022). Der Deutsche Gehirnplan - Agenda 2030. German Brain Council. https:\/\/www.braincouncil.de"},{"key":"494_CR10","unstructured":"DGN, D. G. P. P. N. (2025). S3-Leitlinie Demenzen. Version 50, 28022025; https: DGN e. V. & DGPPN e. V. (Hrsghttps:\/\/register.awmf.org\/de\/leitlinien\/detail\/038\u2009\u2013\u2009013, 12. Juni 2025."},{"key":"494_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston, G., Huntley, J., Sommerlad, A., et al. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet, 396, 413\u201346.","journal-title":"Lancet"},{"key":"494_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2025.105760","volume":"131","author":"B Xin","year":"2025","unstructured":"Xin, B., Zhang, D., Fu, H., & Jiang, W. (2025). Association between multimorbidity and the risk of dementia: A systematic review and meta-analysis. Archives of Gerontology and Geriatrics, 131, Article 105760.","journal-title":"Archives of Gerontology and Geriatrics"},{"key":"494_CR13","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.1002\/alz.13846","volume":"20","author":"SV Asbroeck","year":"2024","unstructured":"Asbroeck, S. V., K\u00f6hler, S., van Boxtel, M. P. J., et al. (2024). Lifestyle and incident dementia: A COSMIC individual participant data meta-analysis. Alzheimer\u2019s Dement, 20, 3972\u20133986.","journal-title":"Alzheimer\u2019s Dement"},{"key":"494_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11121-012-0313-2","volume":"14","author":"KJ Anstey","year":"2013","unstructured":"Anstey, K. J., Cherbuin, N., & Herath, P. M. (2013). Development of a new method for assessing global risk of Alzheimer\u2019s disease for use in population health approaches to prevention. Prevention Science, 14, 411\u2013421.","journal-title":"Prevention Science"},{"key":"494_CR15","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","volume":"69","author":"JA Schneider","year":"2007","unstructured":"Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007). Mixed brain pathologies account for most dementia cases in community-dwelling older personsSYMBOL. Neurology, 69, 2197\u20132204.","journal-title":"Neurology"},{"key":"494_CR16","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu, T., Lehtisalo, J., Solomon, A., et al. (2015). A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. Lancet, 385, 2255\u201363.","journal-title":"Lancet"},{"key":"494_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","volume":"16","author":"S Andrieu","year":"2017","unstructured":"Andrieu, S., Guyonnet, S., Coley, N., et al. (2017). Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): A randomised, placebo-controlled trial. Lancet Neurology, 16, 377\u2013389.","journal-title":"Lancet Neurology"},{"key":"494_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(19)30153-0","volume":"1","author":"E Richard","year":"2019","unstructured":"Richard, E., van Charante, E. P. M., Hoevenaar-Blom, M. P., et al. (2019). Healthy ageing through internet counselling in the elderly (HATICE): A multinational, randomised controlled trial. The Lancet Digital Health, 1, Article e424\u2013e434.","journal-title":"The Lancet Digital Health"},{"key":"494_CR19","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0140-6736(16)30950-3","volume":"388","author":"E Charante","year":"2016","unstructured":"Charante, E., Richard, E., Eurelings, L. S., et al. (2016). Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): A cluster-randomised controlled trial. Lancet, 388, 797\u2013805.","journal-title":"Lancet"},{"key":"494_CR20","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1111\/jgs.16762","volume":"68","author":"M McMaster","year":"2020","unstructured":"McMaster, M., Kim, S., Clare, L., et al. (2020). Lifestyle risk factors and cognitive outcomes from the multidomain dementia risk reduction randomized controlled trial, Body Brain Life for Cognitive Decline (BBL-CD). Journal of the American Geriatrics Society, 68, 2629\u201337.","journal-title":"Journal of the American Geriatrics Society"},{"key":"494_CR21","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/alz.12123","volume":"16","author":"M Kivipelto","year":"2020","unstructured":"Kivipelto, M., Mangialasche, F., Snyder, H. M., et al. (2020). World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia. Alzheimer\u2019s Dement, 16, 1078\u20131094.","journal-title":"Alzheimer\u2019s Dement"},{"key":"494_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/alz.093013","volume":"20","author":"F Mangialasche","year":"2024","unstructured":"Mangialasche, F., Matton, A., Ngandu, T., et al. (2024). The World-Wide FINGERS global strategy for precision prevention of dementia and Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia, 20, Article e093013.","journal-title":"Alzheimer's & Dementia"},{"key":"494_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/jamainternmed.2023.6279","volume":"184","author":"K Yaffe","year":"2024","unstructured":"Yaffe, K., Vittinghoff, E., Dublin, S., et al. (2024). Effect of personalized risk-reduction strategies on cognition and dementia risk profile among older adults. JAMA Internal Medicine, 184, 54\u201362.","journal-title":"JAMA Internal Medicine"},{"key":"494_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14097","author":"AE Z\u00fclke","year":"2024","unstructured":"Z\u00fclke, A. E., Pabst, A., Luppa, M., et al. (2024). Effects of a multidomain intervention against cognitive decline on dementia risk profiles \u2014 Results from the Agewell.de trial. Alzheimer\u2019s & Dementia. https:\/\/doi.org\/10.1002\/alz.14097","journal-title":"Alzheimer's & Dementia"},{"key":"494_CR25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.12923","author":"LD Baker","year":"2025","unstructured":"Baker, L. D., Espeland, M. A., Whitmer, R. A., et al. (2025). Structured vs self-guided multidomain lifestyle interventions for global cognitive function. JAMA. https:\/\/doi.org\/10.1001\/jama.2025.12923","journal-title":"JAMA"},{"key":"494_CR26","volume":"2024","author":"I Toews","year":"2024","unstructured":"Toews, I., Anglemyer, A., Nyirenda, J. L., et al. (2024). Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: A meta-epidemiological study. Cochrane Database of Systematic Reviews, 2024, Article MR000034.","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"494_CR27","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/alz.12748","volume":"19","author":"MS Rafii","year":"2023","unstructured":"Rafii, M. S., Sperling, R. A., Donohue, M. C., et al. (2023). The AHEAD 3-45 study: Design of a prevention trial for Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia, 19, 1227\u201333.","journal-title":"Alzheimer's & Dementia"},{"key":"494_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70662","volume":"21","author":"R Yaari","year":"2025","unstructured":"Yaari, R., Holdridge, K. C., Williamson, M., et al. (2025). Donanemab in preclinical Alzheimer\u2019s disease: Screening and baseline data from TRAILBLAZER-ALZ 3. Alzheimer\u2019s & Dementia, 21, Article e70662.","journal-title":"Alzheimer's & Dementia"},{"key":"494_CR29","volume-title":"World Alzheimer Report. Gauthier S, Webster C, Servaes S, Morais JWorld Alzheimer Report 2022: Life after diagnosis: Navigating treatment, care and support","author":"S Gauthier","year":"2022","unstructured":"Gauthier, S., Webster, C., Servaes, S., Morais, J., & Rosa-Neto, P. (2022). World Alzheimer Report. Gauthier S, Webster C, Servaes S, Morais JWorld Alzheimer Report 2022: Life after diagnosis: Navigating treatment, care and support. Alzheimer\u2019s Disease International."},{"key":"494_CR30","doi-asserted-by":"crossref","unstructured":"WHO WHO. Global status report on neurology. Geneva: World Health Organization (2025). ;: Licence: CCBY-NC-SA 3.0 IGO.","DOI":"10.2471\/B09657"},{"key":"494_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0277037","volume":"17","author":"AE Z\u00fclke","year":"2022","unstructured":"Z\u00fclke, A. E., Luppa, M., K\u00f6hler, S., & Riedel-Heller, S. G. (2022). Knowledge of risk and protective factors for dementia in older German adults A population-based survey on risk and protective factors for dementia and internet-based brain health interventions. PLoS One, 17, Article e0277037.","journal-title":"PLoS One"},{"key":"494_CR32","unstructured":"Collaborators, G., Schumacher, D., & Kyu, A. E. (2021). HH, et al. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950\u20132021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403: 1989\u20132056."},{"key":"494_CR33","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S1474-4422(14)70172-3","volume":"13","author":"K Yaffe","year":"2014","unstructured":"Yaffe, K., Falvey, C. M., & Hoang, T. (2014). Connections between sleep and cognition in older adults. The Lancet Neurology, 13, 1017\u201328.","journal-title":"The Lancet Neurology"},{"key":"494_CR34","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.3233\/JAD-240666","volume":"101","author":"C Rosenau","year":"2024","unstructured":"Rosenau, C., K\u00f6hler, S., van Boxtel, M., Tange, H., & Deckers, K. (2024). Validation of the updated lifestyle for BRAin health (LIBRA) index in the English Longitudinal Study of Ageing and Maastricht Aging Study. Journal of Alzheimer\u2019s Disease, 101, 1237\u20131248.","journal-title":"Journal of Alzheimer's Disease"},{"key":"494_CR35","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche, M. A., & Hyman, B. T. (2020). Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Nature Neuroscience, 23, 1183\u201393.","journal-title":"Nature Neuroscience"},{"key":"494_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/spc3.12265","volume":"10","author":"P Sheeran","year":"2016","unstructured":"Sheeran, P., & Webb, T. L. (2016). The intention\u2013behavior gap. Social and Personality Psychology Compass, 10, 503\u201318.","journal-title":"Social and Personality Psychology Compass"},{"key":"494_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2023.107841","volume":"114","author":"M Spielmann","year":"2023","unstructured":"Spielmann, M., Krolo-Wicovsky, F., Tiede, A., et al. (2023). Patient motivation and preferences in changing co-occurring health risk behaviors in general hospital patients. Patient Education and Counseling, 114, Article 107841.","journal-title":"Patient Education and Counseling"},{"key":"494_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1207\/s15324796abm2701_2","volume":"27","author":"RE Glasgow","year":"2004","unstructured":"Glasgow, R. E., Klesges, L. M., Dzewaltowski, D. A., Bull, S. S., & Estabrooks, P. (2004). The future of health behavior change research: What is needed to improve translation of research into health promotion practice? Annals of Behavioral Medicine, 27, 3\u201312.","journal-title":"Annals of Behavioral Medicine"},{"key":"494_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/1559827610391883","volume":"5","author":"JJ Prochaska","year":"2011","unstructured":"Prochaska, J. J., & Prochaska, J. O. (2011). A review of multiple health behavior change interventions for primary prevention. American Journal of Lifestyle Medicine, 5, 208\u201321.","journal-title":"American Journal of Lifestyle Medicine"},{"key":"494_CR40","unstructured":"Mittelstandsschutz Wirtschaftlicher Erfolg dank betrieblicher Pr\u00e4ventionsma\u00dfnahmen. https:\/\/mittelstandsschutz.de\/magazin\/praeventionsmassnahmen\/"},{"key":"494_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100576","volume":"26","author":"GB Frisoni","year":"2023","unstructured":"Frisoni, G. B., Altomare, D., Ribaldi, F., et al. (2023). Dementia prevention in memory clinics: Recommendations from the European task force for brain health services. The Lancet Regional Health, 26, Article 100576.","journal-title":"The Lancet Regional Health"},{"key":"494_CR42","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu, T., Lehtisalo, J., Solomon, A., et al. (2015). A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial. Lancet, 385, 2255\u201363.","journal-title":"Lancet"},{"key":"494_CR43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jalz.2012.09.012","volume":"9","author":"M Kivipelto","year":"2013","unstructured":"Kivipelto, M., Solomon, A., Ahtiluoto, S., et al. (2013). The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): Study design and progress. Alzheimer\u2019s & Dementia, 9, 657\u201365.","journal-title":"Alzheimer's & Dementia"},{"key":"494_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.765584","volume":"12","author":"N Chowdhary","year":"2022","unstructured":"Chowdhary, N., Barbui, C., Anstey, K. J., et al. (2022). Reducing the risk of cognitive decline and dementia: WHO recommendations. Frontiers in Neurology, 12, Article 765584.","journal-title":"Frontiers in Neurology"},{"key":"494_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003160.pub3","volume":"2016","author":"B McGuinness","year":"2016","unstructured":"McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2016). Statins for the prevention of dementia. Cochrane Database of Systematic Reviews, 2016, Article CD003160.","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"494_CR46","doi-asserted-by":"publisher","first-page":"e3673","DOI":"10.1002\/dmrr.3673","volume":"39","author":"S Tian","year":"2023","unstructured":"Tian, S., Jiang, J., Wang, J., et al. (2023). Comparison on cognitive outcomes of antidiabetic agents for type 2 diabetes: A systematic review and network meta-analysis. DiabetesMetab Res Rev, 39, e3673.","journal-title":"DiabetesMetab Res Rev"},{"key":"494_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12268","volume":"8","author":"CH N\u00f8rgaard","year":"2022","unstructured":"N\u00f8rgaard, C. H., Friedrich, S., Hansen, C. T., et al. (2022). Treatment with glucagon-like peptide\u20101 receptor agonists and incidence of dementia: Data from pooled double\u2010blind randomized controlled trials and nationwide disease and prescription registers. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions, 8, Article e12268.","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"key":"494_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jama.2019.10575","volume":"322","author":"KA Walker","year":"2019","unstructured":"Walker, K. A., Sharrett, A. R., Wu, A., et al. (2019). Association of midlife to late-life blood pressure patterns with incident dementia. JAMA, 322, 535\u201345.","journal-title":"JAMA"},{"key":"494_CR49","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims, J. R., Zimmer, J. A., Evans, C. D., et al. (2023). Donanemab in Early Symptomatic Alzheimer Disease. Journal Of The American Medical Association, 330, 512\u2013527.","journal-title":"Journal Of The American Medical Association"},{"key":"494_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2022","unstructured":"van Dyck, C. H., Swanson, C. J., Aisen, P., et al. (2022). Lecanemab in Early Alzheimer\u2019s Disease. New Engl J Med, 388, 9\u201321.","journal-title":"New Engl J Med"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00494-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-026-00494-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00494-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:29:36Z","timestamp":1781648976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42466-026-00494-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["494"],"URL":"https:\/\/doi.org\/10.1186\/s42466-026-00494-4","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}